Literature DB >> 10338490

Interruption of multiple cellular processes in HT-29 epithelial cells by Pseudomonas aeruginosa exoenzyme S.

J C Olson1, J E Fraylick, E M McGuffie, K M Dolan, T L Yahr, D W Frank, T S Vincent.   

Abstract

Exoenzyme S (ExoS), an ADP-ribosylating enzyme produced by the opportunistic pathogen Pseudomonas aeruginosa, is directly translocated into eukaryotic cells by bacterial contact. Within the cell, ExoS ADP-ribosylates the cell signaling protein Ras and causes inhibition of DNA synthesis and alterations in cytoskeletal structure. To further understand the interrelationship of the different cellular effects of ExoS, functional analyses were performed on HT-29 epithelial cells after exposure to ExoS-producing P. aeruginosa 388 and the non-ExoS-producing strain 388DeltaS. Two different mechanisms of morphological alteration were identified: (i) a more-transient and less-severe cell rounding caused by the non-ExoS-producing strain 388DeltaS and (ii) a more-severe, long-term cell rounding caused by ExoS-producing strain 388. Long-term effects of ExoS on cell morphology occurred in conjunction with ExoS-mediated inhibition of DNA synthesis and the ADP-ribosylation of Ras. ExoS was also found to cause alterations in HT-29 cell function, leading to the loss of cell adhesion and microvillus effacement. Nonadherent ExoS-treated cells remained viable but had a high proportion of modified Ras. While microvillus effacement was detected in both 388- and 388DeltaS-treated cells, effacement was more prevalent and rapid in cells exposed to strain 388. We conclude from these studies that ExoS can have multiple effects on epithelial cell function, with more severe cellular alterations associated with the enzymatic modification of Ras. The finding that ExoS had greater effects on cell growth and adherence than on cell viability suggests that ExoS may contribute to the P. aeruginosa infectious process by rendering cells nonfunctional.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10338490      PMCID: PMC96591          DOI: 10.1128/IAI.67.6.2847-2854.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption.

Authors:  R Rosqvist; A Forsberg; H Wolf-Watz
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

2.  ADP-ribosylation of p21ras and related proteins by Pseudomonas aeruginosa exoenzyme S.

Authors:  J Coburn; D M Gill
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

3.  Several GTP-binding proteins, including p21c-H-ras, are preferred substrates of Pseudomonas aeruginosa exoenzyme S.

Authors:  J Coburn; R T Wyatt; B H Iglewski; D M Gill
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

4.  Exoenzyme S of Pseudomonas aeruginosa ADP-ribosylates the intermediate filament protein vimentin.

Authors:  J Coburn; S T Dillon; B H Iglewski; D M Gill
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

5.  Purification and characterization of exoenzyme S from Pseudomonas aeruginosa 388.

Authors:  S M Kulich; D W Frank; J T Barbieri
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

6.  Small broad-host-range gentamycin resistance gene cassettes for site-specific insertion and deletion mutagenesis.

Authors:  H D Schweizer
Journal:  Biotechniques       Date:  1993-11       Impact factor: 1.993

7.  Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S.

Authors:  T I Nicas; B H Iglewski
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

8.  Pseudomonas aeruginosa exoenzyme S requires a eukaryotic protein for ADP-ribosyltransferase activity.

Authors:  J Coburn; A V Kane; L Feig; D M Gill
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

9.  Cloning the structural gene for the 49-kDa form of exoenzyme S (exoS) from Pseudomonas aeruginosa strain 388.

Authors:  S M Kulich; T L Yahr; L M Mende-Mueller; J T Barbieri; D W Frank
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

10.  Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli.

Authors:  S Knutton; T Baldwin; P H Williams; A S McNeish
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

View more
  17 in total

1.  Differential sensitivity of human epithelial cells to Pseudomonas aeruginosa exoenzyme S.

Authors:  E M McGuffie; J E Fraylick; D J Hazen-Martin; T S Vincent; J C Olson
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

2.  Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates.

Authors:  D Dacheux; I Attree; B Toussaint
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  Examination of the coordinate effects of Pseudomonas aeruginosa ExoS on Rac1.

Authors:  Claudia L Rocha; Elizabeth A Rucks; Deanne M Vincent; Joan C Olson
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Characterization of an ExoS Type III translocation-resistant cell line.

Authors:  Elizabeth A Rucks; Joan C Olson
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

5.  PcrV antibody-antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice.

Authors:  Y Song; M Baer; R Srinivasan; J Lima; G Yarranton; C Bebbington; S V Lynch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-21       Impact factor: 3.267

6.  The ADP-ribosylation domain of Pseudomonas aeruginosa ExoS is required for membrane bleb niche formation and bacterial survival within epithelial cells.

Authors:  Annette A Angus; David J Evans; Joseph T Barbieri; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2010-08-23       Impact factor: 3.441

7.  Comparison of the exoS gene and protein expression in soil and clinical isolates of Pseudomonas aeruginosa.

Authors:  M W Ferguson; J A Maxwell; T S Vincent; J da Silva; J C Olson
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

8.  Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A.1 macrophages.

Authors:  Claudia L Rocha; Jenifer Coburn; Elizabeth A Rucks; Joan C Olson
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Redox-independent activation of NF-kappaB by Pseudomonas aeruginosa pyocyanin in a cystic fibrosis airway epithelial cell line.

Authors:  Christian Schwarzer; Zhu Fu; Horst Fischer; Terry E Machen
Journal:  J Biol Chem       Date:  2008-08-05       Impact factor: 5.157

10.  Pseudomonas aeruginosa population structure revisited.

Authors:  Jean-Paul Pirnay; Florence Bilocq; Bruno Pot; Pierre Cornelis; Martin Zizi; Johan Van Eldere; Pieter Deschaght; Mario Vaneechoutte; Serge Jennes; Tyrone Pitt; Daniel De Vos
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.